Allergy Therapeutics Italy

Allergy Therapeutics Italy is owned by Allergy Therapeutics.

Allergy Therapeutics is a company listed under the stock ticker AGY (GB).

Allergy Therapeutics has a direct presence in 2 countries.

View the org chart displaying its 2 main executives

Most searched biographies at Allergy Therapeutics Italy

• Massimo Collesano, Finance & HR Director and Managing Director
• Luca Marone, Finance and HR Manager

Popular executive movements at Allergy Therapeutics

• Mary Tavener, Non-Executive Director, has left the company  (posted on April 4 2024).

Create your alert
to follow the executive moves at Allergy Therapeutics Italy.

Allergy Therapeutics has 1,867 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Allergy Therapeutics Italy

Social media about Allergy Therapeutics Italy

• Allergy Therapeutics Italy on Wikipedia, Google News & Yahoo Finance
• Allergy Therapeutics Italy on LinkedIn, Twitter & YouTube

Contact by email its executives including Massimo Collesano

Call Allergy Therapeutics Italy at +39...

View the org chart

Register to receive your alert

Report an error